ClinicalTrials.gg
Sign In

Pemphigoid, Bullous clinical trials

The registry lists 64 studies for Pemphigoid, Bullous across more than 10 countries. 8 are recruiting or about to start. 55 of them are mainly about Pemphigoid, Bullous (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-08.

Get an email when these change. Save the Pemphigoid, Bullous studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
32
Status unknown
11
Terminated
7
Recruiting
5
Active, not recruiting
3
Withdrawn
2

Phase

Phase 2
18
Phase 3
12
Phase 1
7
Phase 4
4
Early Phase 1
1

Where

France
28
United States
15
Germany
12
Japan
9
Taiwan
7
China
7

Who runs them

University Hospital, Rouen (6) · CHU de Reims (6) · argenx (2) · Chugai Pharmaceutical (2) · Centre Hospitalier Universitaire de Nice (2) · AKARI Therapeutics (2) · Regeneron Pharmaceuticals (2) · National Taiwan University Hospital (2)

What is being tested here

Drugs under test in Pemphigoid, Bullous studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Stapokibart111
Rituximab024
Efgartigimod alfa022
Hyaluronidase (human recombinant)022
Immunoglobulins, Intravenous012
Immunoglobulin G012
Omalizumab012
Dupilumab011
Clobetasol011
Methotrexate011

Coming up

2phase 3 studies under way
3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Who these studies take

Of the 5 Pemphigoid, Bullous studies recruiting now, 3 (60%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (20%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 5
AgeWomenMen
101 (20%)1 (20%)
184 (80%)4 (80%)
304 (80%)4 (80%)
404 (80%)4 (80%)
504 (80%)4 (80%)
654 (80%)4 (80%)
755 (100%)5 (100%)
855 (100%)5 (100%)

Across all 64 studies, recruiting or not: 2% stop at 75 or younger and 0% at 65; 8% take children; 0% are for women only and 0% for men only; 6% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 64. Browse all 64 → or search them.